Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"

Core Viewpoint - Growth investors are attracted to stocks with above-average financial growth, but identifying such stocks can be challenging due to inherent risks and volatility [1] Group 1: Company Overview - HealthEquity (HQY) is identified as a promising growth stock, supported by a favorable Growth Score and a top Zacks Rank [2] - The company provides services for managing health care accounts, making it a relevant choice for growth investors [3] Group 2: Earnings Growth - HealthEquity has a historical EPS growth rate of 19.1%, with projected EPS growth of 19.3% for the current year, significantly outperforming the industry average of 8.5% [5] Group 3: Cash Flow Growth - The year-over-year cash flow growth for HealthEquity stands at 25.9%, well above the industry average of -1.5% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 19.3%, compared to the industry average of 7.6% [7] Group 4: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for HealthEquity, with the Zacks Consensus Estimate for the current year increasing by 9.2% over the past month [8] Group 5: Investment Potential - HealthEquity holds a Zacks Rank of 2 (Buy) and a Growth Score of B, indicating its potential as an outperformer and a solid choice for growth investors [10]